Tirzepatide interactions with other drugs: what the evidence actually says

The myth that tirzepatide is largely free of drug interactions

It's surprisingly common to read that tirzepatide has a 'clean' interaction profile. That framing isn't entirely wrong (it doesn't inhibit or induce the major cytochrome P450 enzymes that cause many classic drug-drug interactions) but it encourages people to skip a conversation with their prescriber that is genuinely important. The interactions that do exist are pharmacodynamic and pharmacokinetic in nature, and a few of them have real clinical weight.

The most significant mechanism to understand is delayed gastric emptying. Tirzepatide slows the rate at which your stomach moves its contents into the small intestine. For most foods that's the intended effect, producing satiety and blunting post-meal glucose spikes. For oral medicines that depend on predictable absorption from the gut, it can mean lower or delayed peak levels. If you take medicines where timing or blood concentration is critical (levothyroxine, certain antibiotics, the combined oral contraceptive pill) this matters. A thorough overview of how tirzepatide works as a dual GIP and GLP-1 receptor agonist is on the tirzepatide overview page.

None of this means tirzepatide is contraindicated with those medicines. It means the prescriber needs to know about them, and in some cases timing or formulation adjustments are appropriate. The myth that there's little to declare is the most dangerous starting point of all.

Blood-glucose medicines: the interaction that needs active management

If you take insulin or a sulfonylurea (glibenclamide, gliclazide, glipizide and others), starting tirzepatide substantially increases the risk of hypoglycaemia. Both the BNF and the Mounjaro SmPC note this explicitly: tirzepatide lowers blood glucose independently, and stacking it with medicines that do the same (particularly insulin secretagogues) can push glucose too low.

This isn't a reason to avoid tirzepatide if you have type 2 diabetes; it's a reason for the prescribing clinician to review doses before and during treatment. In clinical practice, sulfonylurea or insulin doses are often reduced when tirzepatide is introduced. The prescriber decides this on a case-by-case basis. You'll find a detailed discussion of how this plays out specifically with Mounjaro on the Mounjaro interactions page.

Metformin, by contrast, carries minimal hypoglycaemia risk on its own and is commonly co-prescribed with tirzepatide without dose adjustment, though the prescriber reviews it regardless. SGLT-2 inhibitors and DPP-4 inhibitors sit in a middle ground and need individual assessment. Keep your tirzepatide pen in the fridge door alongside any insulin you use, both need refrigerated storage, and keeping them together makes the daily routine easier to sustain.

Oral contraceptives and the four-week rule

This is one of the most clinically specific interactions, and one that catches people off guard. Because tirzepatide delays gastric emptying, it can reduce the absorption of the combined oral contraceptive pill, potentially lowering its effectiveness. The NHS advises that women using oral contraceptives should add a non-oral method of contraception (condoms, for instance) for the first four weeks of starting tirzepatide, and for four weeks after each dose increase thereafter.

This recommendation applies specifically to tirzepatide. There isn't equivalent published evidence of the same effect with semaglutide, so if you've previously taken Wegovy without this precaution, don't assume tirzepatide follows the same rules. For a broader look at what drugs interact with Mounjaro, including the contraception detail in context, that page covers the topic in depth.

HRT is a related question. NHS England advises considering transdermal HRT (patches or gels rather than tablets) while taking tirzepatide, again because the absorption of oral hormone preparations may be affected. If you take oral HRT, raise it at your consultation. It's a question our prescribers hear regularly, and it's straightforward to address when it's on the table from the start. You can review how tirzepatide sits alongside other common medicines for more on this.

Other medicines to flag, and how to approach your consultation

Beyond the categories above, a handful of other interactions are worth naming. Warfarin users should be aware that changes in diet and weight can shift INR, and some GLP-1 medicines have been associated with altered anticoagulant response, more frequent INR monitoring may be appropriate when starting treatment. Anyone taking medicines with a narrow therapeutic index (digoxin, certain antiepileptics, ciclosporin) should ensure their prescriber knows, because even modest changes in absorption timing can be clinically relevant.

Over-the-counter NSAIDs are worth mentioning too. Tirzepatide can cause gastrointestinal side effects, particularly in the early weeks, and regular NSAID use on top of that may worsen stomach irritation. It's not a contraindication, but it's worth flagging.

The practical approach is straightforward: write down everything you take before your consultation (prescription medicines, OTC products, vitamins, herbal supplements) and share it in full. If you're thinking about starting treatment, check your eligibility with our prescribers, who review every application individually. You can also read whether Mounjaro has drug interactions in a focused Q-and-A format, or explore the fuller Mounjaro medication interactions reference if you want the clinical detail in one place. Our clinical team includes GPhC-registered Independent Prescribers who assess each case on its merits, no shortcuts, no automation.